Diastolic dysfunction and exercise capacity in patients with metabolic syndrome and overweight/obesity

Abstract

BackgroundLeft ventricle diastolic dysfunction (LVDD) is a common finding in high risk individuals, its presence being associated with reduced exercise capacity (EC). We assessed the prevalence of LVDD, applying the 2016 guidelines of the American Society of Echocardiography (ASE)/European Association of Cardiovascular Imaging (EACVI), in a population with overweight/obesity and metabolic syndrome and its association with EC.Methods and resultsThis was a prospective, cross-sectional study of a cohort of 235 patients (mean age of 65 ± 5 years old and 33% female) without heart disease and an ejection fraction >50% who underwent a complete echocardiographic assessment and cardiopulmonary exercise testing. Individuals meeting three or more criteria of the 2016 ASE/EACVI guidelines are considered to have LVDD, while tests are considered indeterminate in those meeting only two. Overall, 178 (76%) of our patients met one echocardiographic cutoff value for LVDD, 91 (39%) met two and 7 (3%) three or more. Patients meeting three cutoffs values showed a significant reduction in maximal oxygen uptake (16 ± 3 vs. 19.6 ± 5 ml/kg/min, p < .05), unlike those with indeterminate tests. In multiple regression analysis, meeting three cutoffs was associated with number of METS (ß = −2.2, p = .018). In exploratory analysis, using two criteria based on cutoffs different from those proposed in the guidelines, we identified groups with different EC.ConclusionsThe application of 2016 ASE/EACVI guidelines limited the prevalence of LVDD to 3%. This group showed a clear reduction of the EC. New echocardiographic cutoff values proposed in this study allow us to establish subgroups with different levels of EC.

Exercise Training Improves Memory Performance in Older Adults: A Narrative Review of Evidence and Possible Mechanisms

“…Metabolic syndrome is a complex condition characterized by insulin resistance, hyperglycemia, dyslipidemia, and obesity (Alonso-Gómez et al, 2019), and stands as a risk factor for cognitive decline and Alzheimer's disease (Razay et al, 2007;Farooqui et al, 2012;Neergaard et al, 2017;Kong et al, 2018). One of the features of metabolic syndrome, is the excess visceral fats producing inflammatory cytokines which are named adipokines.…”

Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives

“…The latter algorithm, on the other hand, also resulted in labeling 36 patients as “indeterminate”, compared to no such cases when the former was applied [50]. Another application of the same guideline on a cohort of 235 Spanish patients with metabolic syndrome, of which 52 confirmed diabetics, resulted in a prevalence of diastolic dysfunction as low as 3%, while 58% were rated as normal and 39% were “indeterminate” before conducting further cardiopulmonary exercise tests [53].…”

Exercise training modulates adipokine dysregulations in metabolic syndrome

“…Metabolic syndrome (MetS) is a clustering of symptoms or conditions including; central obesity, high blood pressure, hyperglycemia, insulin resistance, and dyslipidemia. 1 Among them, central obesity, has been viewed as a serious problem of the 21 st -century, 2 and is associated with various metabolic disorders. 3 Excess visceral fat, causes the secretion of bioactive peptides; known as adipokines, and thus, links with other parts of the body.…”